New hires receive 65,350 stock options at BridgeBio Oncology

robot
Abstract generation in progress

BridgeBio Oncology Therapeutics (NASDAQ: BBOT) announced that two new employees hired in January 2026 were awarded 65,350 non-qualified stock options on February 10, 2026. The options have an exercise price of $10.84 per share and will vest 25% after one year, then monthly over 36 months, according to the company’s 2025 Inducement Plan. This grant, approved by the compensation committee, is in compliance with Nasdaq Listing Rule 5635©(4).

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin